Log In
Print this Print this

Hectorol, doxercalciferol

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSynthetic vitamin D analog
Molecular Target Not available
Mechanism of ActionNA
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThyroid disease
Indication DetailsManage secondary hyperparathyroidism (SHPT) in chronic dialysis patients; Reduce elevated parathyroid hormone levels in the management of secondary hyperparathyroidism (SHPT); Treat secondary hyperparathyroidism (SHPT) in pre-dialysis renal disease; Treat secondary hyperparathyroidism (SHPT) in pre-dialysis stage III and IV chronic kidney disease (CKD) patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today